drugset / Trial / NCT00000580

Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin

NCT00000580

RandomizedDouble-blindPrevention

Summary

To evaluate whether hepatitis B immune globulin with a high level of antibody against the hepatitis B antigen would be capable of interrupting maternal-fetal transmission of hepatitis B virus, the single most important route of hepatitis spread in the entire Third World.

Timeline

Start
1975-11
Primary completion
Completion
1986-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject hepatitis B immune globulin Protein / enzyme biologic Intravenous
Subject standard immune globulin Protein / enzyme biologic Intravenous